Publications: Mr Martin Vu

Vu M, Degeling K, Westerman D, IJzerman MJ ( 2024 ) . Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients . Journal of Cancer Policy vol. 41 ,

Vu M, Degeling K, Ryland GL, Hofmann O, Ng AP, Westerman D, IJzerman MJ ( 2024 ) . Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia . Journal of Molecular Diagnostics vol. 26 , ( 8 ) 673 - 684 .

Vu M, Degeling K, Thompson ER, Blombery P, Westerman D, IJzerman MJ ( 2023 ) . Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia . Applied Health Economics and Health Policy vol. 22 , ( 1 ) 107 - 122 .

Fagery M, Khorshidi HA, Wong SQ, Vu M, IJzerman M ( 2023 ) . Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review . PharmacoEconomics vol. 41 , ( 10 ) 1229 - 1248 .

Vu M, Degeling K, Thompson ER, Blombery P, Westerman D, IJzerman MJ ( 2022 ) . Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review . European Journal Of Haematology vol. 108 , ( 6 ) 469 - 485 .

Vu M, Carvalho N, Clarke PM, Buchbinder R, Tran-Duy A ( 2020 ) . Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis . The Journal of Rheumatology vol. 48 , ( 8 ) 1221 - 1229 .

Vu M, Degeling K, Martyn M, Lynch E, Chong B, Gaff C, IJzerman MJ ( 2020 ) . Evaluating the resource implications of different service delivery models for offering additional genomic findings . Genetics in Medicine vol. 23 , ( 4 ) 606 - 613 .

Degeling K, Vu M, Koffijberg H, Wong H-L, Koopman M, Gibbs P, IJzerman M ( 2020 ) . Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review . PharmacoEconomics vol. 38 , ( 7 ) 683 - 713 .